ASCO has partnered with Health Volunteers Overseas (HVO), an international medical education organization, to give ASCO’s member oncologists an opportunity to support cancer care medical centers in developing countries, share their medical expertise, and build long-term, supportive relationships with the doctors who provide cancer care in these countries.
ICC volunteers are paired with a medical center where the training needs of the facility match the expertise of the volunteer. Volunteers spend one to four weeks onsite, where they will teach and train staff, residents, and students, and gain insights into the center’s cancer management needs and challenges. While ICC volunteers will not treat patients directly, their value will be in sharing their clinical knowledge and skills with their international colleagues. Upon their return to the United States, ASCO’s member volunteers will continue to share the Society’s professional resources with the medical center to help sustain and improve cancer care in the region.
ASCO Program Sites:
Tegucigalpa, Honduras
Other sites TBD in 2010!
Program:
This program focuses on the ongoing development of an oncology training program for both adult and pediatric oncology at three centers in Tegucigalpa, the capital of Honduras: the Hospital Escuela, the Hospital San Felipe, and the Cancer Center Emma Callejas.Assignments range from 1 to 4 weeks.
Goals:
To provide teaching and training to staff, residents, and students at three hospitals in the capital city of Tegucigalpa. Training activities fall under five main categories:
1. Pathology
2. Cancer Control
3. Medical/Surgical/Radiation Oncology Seminars and/or Workshops
4. Curriculum Development
5. Student and Resident Education
Volunteer Qualifications:
Volunteers must be appropriately trained and credentialed medical professionals who specialize in oncology. This includes physicians (medical, radiation, and surgical oncology), laboratory professionals, and nurses.
To find out more information, fill out a
volunteer interest form today.